Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5525_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Acknowledgments
- •Editor biographies
- •Yi Wang
- •X. Sharon Qi
- •List of contributors
- •1.2.3 Feature engineering and representation
- •1.2.4 Linear separability
- •1.2.5 Classical models
- •1.1 A brief introduction to AI
- •1.2 Machine learning basics
- •1.2.1 Learning paradigms
- •1.3 Artificial neural networks
- •1.3.1 Feed-forward neural networks
- •1.3.2 Recurrent neural networks
- •1.3.3 Convolutional neural networks
- •1.3.4 Attention
- •1.3.5 Training neural networks
- •1.3.6 Applications and use cases of deep learning
- •1.4 Model training and evaluation
- •1.4.1 Hyperparameters
- •1.4.2 Data split
- •1.4.3 Evaluation metrics
- •1.5 Generative models
- •1.5.1 Generative adversarial networks
- •1.5.2 Diffusion models
- •1.5.3 Applications and use cases
- •1.6 Ethical consideration and bias
- •1.6.1 Transparency and explainability
- •1.6.2 Bias and fairness
- •1.6.3 Data privacy violation
- •1.6.4 Risk and misuse
- •1.7 Summary
- •References
- •2.1 Introduction
- •2.1.2 Staff roles in radiation therapy
- •2.2 Overview of AI in radiation therapy
- •2.2.1 Patient evaluation and dose prescription
- •2.2.2 Treatment simulation
- •2.2.3 Contouring
- •2.2.4 Treatment planning
- •2.2.5 Quality assurance
- •2.2.6 Treatment delivery
- •2.2.7 Response assessment and toxicity management
- •2.3 Summary
- •3.1 Introduction
- •3.1.1 Introduction of clinical decision making and AI
- •3.1.2 The role of AI in clinical decision making
- •3.2 AI algorithms for clinical decision making
- •3.2.2 Radiomics
- •3.2.3 Data integration by AI
- •3.2.4 Interpretability of AI models
- •3.3 Application of AI in clinical decision making
- •3.3.1 Diagnosis and disease phenotyping
- •3.3.2 Personalized treatment
- •3.3.3 Treatment outcome and prognosis prediction
- •3.4 Challenges and future directions of AI in clinical decision making
- •3.4.1 Challenges and concerns
- •3.4.2 Future directions
- •3.5 Summary
- •References
- •4.1 Introduction
- •4.2 Imaging for treatment planning
- •4.2.1 CT simulation
- •4.2.2 4D-CT
- •4.2.3 PET/CT
- •4.2.4 MRI
- •4.3 Imaging for treatment guidance
- •4.3.1 Portal imaging
- •4.3.2 CBCT
- •4.3.3 CT-on-rail and CT-linac
- •4.3.4 MR-linac
- •4.3.5 PET-linac
- •4.4 Imaging for motion management
- •4.4.1 ExacTrac
- •4.4.2 Varian triggered imaging
- •4.4.3 4D-CBCT
- •4.4.4 Cine MRI
- •4.4.5 4D-MRI
- •4.4.6 Surface imaging
- •4.5 Imaging for treatment assessment
- •4.5.1 Contrasted CT
- •4.5.2 PET/CT
- •4.5.3 Functional MRI
- •4.6 Summary
- •5.1 Introduction to big data in radiation oncology
- •5.1.1 Overview of big data
- •5.1.2 Sources of big data in radiation oncology
- •5.1.3 Big data and AI in radiation oncology
- •5.2 Big data lifecycle in radiation oncology
- •5.2.1 Data aggregation and storage
- •5.2.2 Data sharing and security
- •5.4 The application of big data in radiation oncology
- •5.4.1 Medical image segmentation
- •5.4.2 Automatic treatment planning
- •5.4.3 Treatment response prediction
- •5.4.4 Quality assurance and patient safety
- •5.4.5 Clinical decision support
- •5.2.3 Data visualization
- •5.2.4 Knowledge creation and implementation
- •5.2.5 Data archiving and deletion
- •5.3 Big data analytics with AI
- •5.3.1 Data processing and integration
- •5.3.2 AI modeling
- •5.5 Challenges and future perspectives
- •5.6 Summary
- •Reference
- •6.1 The road to ART
- •6.1.1 3D conformal radiotherapy (3DCRT)
- •6.1.2 Intensity modulated radiotherapy (IMRT)
- •6.1.3 Image-guided radiotherapy (IGRT)
- •6.1.4 Adaptive radiotherapy (ART)
- •6.2 ART workflow and implementation
- •6.2.2 Current practice
- •6.2.3 Clinical impact
- •6.3 Considerations for implementing online ART
- •6.3.1 Time as a limiting factor
- •6.3.2 Implications for fast and reliable re-planning
- •6.3.4 Clinical considerations
- •6.4 Summary
- •7.1 Components of ART workflow
- •7.1.1 Simulation
- •7.1.2 Pre-planning
- •7.1.3 Online imaging and daily re-planning
- •7.1.4 Quality assurance
- •7.2 AI-driven ART
- •7.2.1 Simulation
- •7.2.2 Pre-planning
- •7.2.3 AI for delivery
- •7.3 Outlook and future directions
- •7.3.1 Real-time ART with AI
- •7.3.2 Dose escalation and functional adaption with AI
- •7.4 Summary
- •References
- •8.1 Introduction
- •8.2 Synthetic CT: deep learning methods
- •8.2.1 Conventional methods
- •8.2.2 U-Net
- •8.2.3 Generative adversarial networks
- •8.2.4 Denoising diffusion probabilistic model
- •8.3 Synthetic CT from CBCT
- •8.3.1 Noise and artifact reduction
- •8.3.2 Online dose calculation
- •8.3.3 Online image segmentation
- •8.4 Synthetic CT from MRI
- •8.4.1 Synthetic image accuracy
- •8.4.2 Dose calculation in MR-only radiation therapy
- •8.4.3 PET attenuation correction
- •8.4.4 Image registration
- •8.5 Discussion and outlook
- •8.6 Summary
- •References
- •9.1 AI-based image registration and segmentation for ART
- •9.1.1 Adaptive radiation therapy
- •9.2 Artificial intelligence
- •9.2.1 What is machine learning?
- •9.2.2 What is deep learning?
- •9.3 Deep learning: the basic components
- •9.3.1 Convolutional neural networks: looking at the picture
- •9.3.2 Pooling layers: keeping what matters most
- •9.3.3 Fully connected (dense) layers: bringing it all together
- •9.3.4 Activations
- •9.3.5 Loss: driving the model
- •9.3.6 Auto-encoders: remove the noise
- •9.3.7 Supervised versus unsupervised learning
- •9.3.8 Pre-trained convolutional neural networks
- •9.4 Image registration: bringing two images together
- •9.4.1 Registration similarity metrics
- •9.4.2 Types of registrations
- •9.5 AI-based image registration
- •9.5.1 Supervised learning
- •9.5.2 Unsupervised learning
- •9.5.3 Registration in ART
- •9.5.4 Commonalities in architectures
- •9.6 Image segmentation
- •9.6.1 Introduction: coloring by the numbers
- •9.6.2 Segmentation networks
- •9.6.3 Best practices
- •9.7 Summary
- •10.1 Introduction
- •10.1.1 Overview of chapter content
- •10.2 The landscape of AI-assisted dose prediction
- •10.2.1 Traditional machine learning for dose prediction
- •10.2.2 Deep learning-based dose prediction
- •10.2.3 Challenges in AI-assisted dose prediction
- •10.3 Re-planning workflows powered by AI
- •10.3.1 Deep learning for re-planning pipelines
- •10.4 Future directions of AI-assisted dose prediction and re-planning
- •10.5 Summary
- •11.1 Introduction
- •11.2.1 Imaging-based motion monitoring
- •11.2.2 Delivery system actions
- •11.2.3 Challenges for real-time ART implementation
- •11.3 AI in real-time ART workflows
- •11.3.1 Improving intrafraction motion monitoring through AI
- •11.3.2 Mitigating system latency through AI
- •11.4 AI for ART delivery: future directions
- •11.4.1 Management of non-respiratory motion
- •11.4.2 Training AI models with small or unpaired datasets
- •11.4.4 Biology-guided ART delivery
- •11.5 Summary
- •References
- •12.1 Introduction
- •12.2 Patient QA
- •12.2.1 Pre-planning QA
- •12.2.2 Pre-treatment plan QA
- •12.2.3 On-treatment QA
- •12.3 Treatment delivery systems and instruments
- •12.3.1 Machine commissioning
- •12.3.2 Machine QA
- •12.3.3 Dosimetry tool QA
- •12.4 Summary
- •References
- •13.1 Data resources for response modeling in radiotherapy
- •13.1.1 Clinical data
- •13.1.2 Imaging (radiomics)
- •13.1.3 Treatment planning (dosiomics)
- •13.1.4 Multiomics
- •13.2 Radiotherapy treatment outcome modeling
- •13.2.1 TCP/NTCP in radiotherapy
- •13.2.2 Clinical outcomes versus PROs
- •13.2.3 Machine learning response prediction
- •13.2.4 Explainability of ML response models
- •13.2.5 Sample use cases
- •13.3 AI response-based adaptive radiotherapy
- •13.3.1 Requirements and challenges
- •13.3.2 Prediction versus treatment optimization
- •13.3.3 Sample use cases
- •13.4 Challenges and recommendations
- •13.5 Summary
- •Acknowledgments
- •References
- •14.1 Overview of challenges in AI-driven ART
- •14.2 Data challenges
- •14.2.1 Data availability
- •14.2.2 Data quality
- •14.2.3 Data privacy
- •14.3 Technical challenges
- •14.3.2 Model robustness and generalizability
- •14.3.3 Model explainability and interpretability
- •14.4 Challenges associated with online and real-time workflows
- •14.4.1 Image quality
- •14.4.2 Dose calculation
- •14.4.3 Real-time ART
- •14.5 Operational challenges
- •14.5.1 Clinical validation
- •14.5.3 Staff training
- •14.5.4 User experiences
- •14.5.5 Quality management program
- •14.5.6 Financial challenges
- •14.6 Ethical, regulatory, and legal challenges
- •14.6.1 Ethical issues
- •14.6.2 Regulatory and legal issues
- •14.7 Summary
- •References
- •15.1 Clinical considerations for CT-based offline ART
- •15.1.1 Patient and site selection
- •15.1.2 Re-simulation
- •15.1.3 Re-planning
- •15.1.4 Plan summation and evaluation
- •15.1.6 Limitations and future directions
- •15.2 Clinical considerations for CBCT/CT-based online ART
- •15.2.2 Patient and site selection
- •15.2.3 Simulation
- •15.2.4 Pre-planning review
- •15.2.5 Reference planning
- •15.2.9 Limitations and future directions
- •15.3 Summary
- •References
- •16.1 Introduction
- •16.2 Overview of MRI-guided ART systems
- •16.3 MRI-guided ART workflow
- •16.4 AI applications for MRI-guided ART
- •16.4.1 Synthetic CT generation
- •References
- •16.4.2 Auto-segmentation
- •16.4.3 Image registration
- •16.4.4 Others
- •16.4.5 Future AI development and implementation
- •16.5 Summary
- •17.1 Functional PET-guided ART
- •17.1.1 PET-based functional imaging overview
- •17.1.2 From anatomy to function: the power of PET in radiation therapy
- •17.1.5 Conclusions and future prospects
- •17.2 Functional MRI-guided ART
- •17.2.1 From anatomy to function: the power of functional MRI in radiation therapy
- •17.2.4 Conclusion and future prospects
- •17.3 Summary
- •References
- •18.1 Proton ART
- •18.1.1 Clinical context and necessity
- •18.1.2 Patient populations
- •18.1.4 Rationale for AI in proton ART
- •18.2 AI in proton ART
- •18.2.1 Imaging
- •18.2.2 Deformable and rigid registration
- •18.2.3 Contour propagation
- •18.2.4 Dose calculations
- •18.2.5 Plan optimization
- •18.2.6 Other developments
- •18.3 Implementation of adaptive proton therapy
- •18.4 Summary
- •References
- •19.1 Designing clinical trials with AI
- •19.1.1 The essential role of clinical trials
- •19.1.2 Trial protocols and methodologies
- •19.1.3 AI-driven clinical trial design and execution
- •19.1.4 Incorporation of digital twins (DTs) in clinical trials
- •19.2 Implementation of AI in ongoing clinical trials
- •19.2.1 Integration with existing clinical trial frameworks
- •19.2.2 Quality assurance, compliance, and standardization
- •19.3 Case studies of AI in adaptive radiotherapy trials
- •19.3.1 Overview of guidance for advanced radiotherapy in clinical trials
- •19.3.2 AI in the radiotherapy clinical trial quality assurance processes
- •19.4 Ethical and regulatory considerations
- •19.4.1 Patient consent and data privacy
- •19.4.2 Bias, fairness, and transparency
- •19.4.3 Regulatory guidelines and compliance
- •19.5 Future directions and challenges
- •19.5.1 Emerging technologies and techniques
- •19.5.2 Alternative strategies
- •19.6 Conclusion
- •19.7 Summary
- •References
- •20.1 Risk management
- •20.1.1 Prospective risk assessments
- •20.1.2 Root cause analysis

Artificial Intelligence in Adaptive Radiation Therapy
Medical images, which include various modalities such as MRI, CT, and PET,
play crucial roles in clinical decision-making throughout the diagnosis and treatment
process. Foundation models hold immense potential to transform the utilization of
medical images [115]. For instance, it is poised to revolutionize the field by
introducing a new generation of versatile digital radiology assistants [125]. These
assistants can support radiologists throughout their workflow, significantly reducing
their workloads. Additionally, foundation models can integrate imaging with other
multi-modal sources such as text, providing both model auditing and annotated
images [126]. Text-to-image generative models, such as DALL-E [127], demonstrate
promising performance in medical image generation and augmentation [128].
Biological data—including DNA and RNA sequences, genetic variations such
as DNA copy number variations and DNA methylation patterns, and gene
expression profiles from miRNA and single-cell RNA —hold significant potential
for guiding decision-making in precision oncology. Public databases such as
TCGA, Gene Expression Omnibus [129], and Protein Data Bank [130] serve as
invaluable resources for researchers, enriching our understanding of cancer
biology and guiding personalized treatment strategies to improve patient outcomes. Ongoing efforts to develop foundation models for biological sequences
[131] facilitate various tasks, including multi-omic integration [132], RNA and
protein function prediction [133], and genetic variant effect prediction [134].
Additionally, various foundation models have been utilized to assist in determining treatment options based on molecular profiles and genetic alterations for
cancer patients [135]. Looking ahead, foundation models hold tremendous
potential for integrating multi-modal data, such as spatial transcriptome, DNA
and RNA raw sequencing data, and accompanying EHRs and medical imaging, to
transform traditional analytical approaches in cancer prognosis.
In summary, the integration of foundation models into clinical decision support
systems holds great promise for advancing medical decision-making processes,
although challenges remain in ensuring accuracy, privacy, and safety. Ongoing
research and development efforts are critical in addressing these challenges and
realizing the full potential of AI in healthcare.
5.5 Challenges and future perspectives
While the potential of big data in radiation oncology is enormous, its application is
not without challenges. With data coming from various sources and in different
formats, one of the foremost challenges is to ensure data quality and standardization. Robust model development and implementation require standardizing data
analysis frameworks.
Most studies trained their AI models using a single-institutional dataset, which
may lead to poor model generalizability in other institutions. This happens due to
domain shifts arising from variations in patient populations, clinical protocols,
imaging equipment, etc. Transfer learning [136] could help address domain shift
issues and improve model robustness in real-word applications. Multi-institutional
collaboration is another approach to reduce data biases, comply with regulatory
5-17

Artificial Intelligence in Adaptive Radiation Therapy
guidelines that emphasize inclusivity and fairness, and enhance model performance.
However, sharing data across institutions could potentially pose risks to data
privacy and security. Given the sensitive nature of patient data, it is critical to
ensure data confidentiality and protect against data breaches, which requires robust
cybersecurity measures and adherence to regulations such as HIPAA. Federated
learning is another essential technique to address the risks of data sharing across
different institutions.
Translating the values from big data into clinical practice presents further
challenges. For example, expensive prospective clinical trials may be required to
test the safety and efficacy of the models for regulatory approval. Once approved,
physicians must understand and trust AI models to be on board with clinical
implementation. The decision-making process in many AI models’ learning,
particularly deep learning, is frequently perceived as a ‘black box’ due to their
intricate and opaque decision-making processes. Explainable AI (XAI) [137] plays a
crucial role in bringing transparency and building trust in the high-stakes clinical
decision-making process that directly impacts patient lives. For clinicians, understanding and justifying AI-driven predictions is essential for patient safety and
ethical care. By providing clear explanations, XAI can help prevent mistakes,
support adherence to regulatory standards, and encourage responsible AI use in
healthcare. Additionally, uncertainty quantification [138] could be applied to
generate model predictions along with uncertainty estimation, which is critical for
clinicians to evaluate the reliability of the predictions and identify challenging cases
that need to be examined carefully. Moreover, there is an increasing demand for
advanced computational infrastructures and skilled personnel to manage and
analyse big data in radiation oncology. More efforts should be made to address
these challenges.
Looking ahead, the evolving landscape of big data in radiation oncology is
poised to revolutionize the field with more personalized, efficient, and effective
treatment strategies. The emerging multi-omics data analysis is expected to
provide deeper insights into the complexities of cancer biology and the varying
responses of different cancers to treatments. By analyzing patterns and correlations using big data, researchers could identify new biomarkers and understand the
molecular and genetic underpinnings of individual tumors. This could lead to a
new era of radiation therapy, characterized by highly adaptive and personalized
treatment regimens.
The integration of AI and big data is anticipated to enhance healthcare operational efficiency, facilitate more effective and cost-saving clinical workflows, streamline administrative processes, and optimize resource allocation. Big data
applications also have the potential for remote patient monitoring, ensuring timely
intervention during post-treatment follow-ups. Additionally, big data may empower
patients with easy access to their health data, providing customized visualizations
and enhancing patient engagement in treatment. This, in turn, could potentially
improve patients’ adherence to clinicians’ instructions and ultimately enhance
treatment outcomes.
5-18

Artificial Intelligence in Adaptive Radiation Therapy
5.6 Summary
In this chapter, we reviewed the transformative role of big data in advancing AI in
radiation oncology. Diverse and large-scale datasets—spanning imaging, EMRs,
biological sequences, and multi-omics—fuel increasingly powerful AI models that
drive precision, efficiency, and personalization in cancer care. We outlined a typical
big data lifecycle, emphasizing data aggregation, storage, sharing, visualization, and
knowledge implementation. We then discussed AI techniques for big data processing, integration, and modeling, ranging from classical machine learning and deep
learning to reinforcement learning and emerging foundation models. These
approaches enable the applications in medical image segmentation, treatment
planning, response prediction, quality assurance, and clinical decision support.
Lastly, we identified the challenges including data heterogeneity, limited generalizability of institution-specific models, privacy concerns, and the opacity of AI
models. Solutions such as transfer learning, multi-institutional collaboration,
explainable AI, and uncertainty quantification are essential to ensure safe and
trustworthy clinical integration.
The future of precision radiation oncology lies in analyzing big data using AI
models. By harnessing these advances, the field is poised to deliver data-driven and
personalized radiation therapy that could potentially improve outcomes and
redefine standards of cancer care.
Reference
[1] Chen C L P and Zhang C Y 2014 Data-intensive applications, challenges, techniques and
technologies: a survey on Big Data Inf. Sci.
[2] Laney D 2001 3D data managment: controlling data volume, velocity and variety
Application Delivery Strategies, Technical Report 494 META Group, Brussels 51
[3] Rubin V L 2014 Veracity roadmap: is big data objective, truthful and credible? Adv. Class.
Res. Online
[4] Roski J, Bo-Linn G W and Andrews T A 2014 Creating value in health care through big
data: opportunities and policy implications Health Aff.
[5] Zeng J and Glaister K W 2018 Value creation from big data: looking inside the black box
Strateg. Organ.
[6] Dutta K 2017 Distributed computing technologies in big data analytics Distributed
Computing in Big Data Analytics
R Singh Bhadoria and G Deka (Cham: Springer)
[7] Desarkar A and Das A 2017 Big-data analytics, machine learning algorithms and scalable/
parallel/distributed algorithms Internet of Things and Big Data Technologies for Next
Generation Healthcare
[8] Liu X, Iftikhar N and Xie X 2014 Survey of real-time processing systems for big data ACM
Int. Conf. Proc. Ser. (New York: Association for Computing Machinery) pp 356–61
[9] Rao T R, Mitra P, Bhatt R and Goswami A 2019 The big data system, components, tools,
and technologies: a survey Knowl. Inf. Syst.
[10] Hashem I A T, Yaqoob I, Anuar N B, Mokhtar S, Gani A and Ullah Khan S 2015 The rise
of ‘big data’ on cloud computing: review and open research issues Inf. Syst.
24 4–15
16 105–40
Scalable Computing and Communications S Mazumder,
Studies in Big Data vol 23 (Cham: Springer) pp 159–97
275 314–47
33 1115–22
60 1165–245
47 98–115
5-19

Artificial Intelligence in Adaptive Radiation Therapy
[11] Anshari M, Almunawar M N, Lim S A and Al-Mudimigh A 2019 Customer relationship
management and big data enabled: personalization and customization of services Appl.
Comput. Inform.
[12] Awan M J, Rahi m M S M, Nobanee H, Munawar A, Yasin A and Zain A M 2021 Social
media and stock market prediction: a big data approach Com put. Mater. Contin.
2569–83
[13] Chen G et al 2022 Rapid progress in intelligent radiotherapy and future implementation
Cancer Invest.
[14] Lyu H G, Haider A H, Landman A B and Raut C P 2019 The opportunities and
shortcomings of using big data and national databases for sarcoma research Cancer
2926–34
[15] Mayo C S et al 2018 Treatment data and technical process challenges for practical big data
efforts in radiation oncology Med. Phys.
[16] Benedict S H, El Naqa I and Klein E E 2016 Introduction to big data in radiation oncology:
exploring opportunities for research, quality assessment, and clinical care Int. J. Radiat.
Oncol. Biol. Phys.
[17] Potters L, Ford E, Evans S, Pawlicki T and Mutic S 2016 A systems approach using big
data to improve safety and quality in radiation oncology Int. J. Radiat. Oncol. Biol. Phys.
95 885–9
[18] McNutt T R et al 2018 Using big data analytics to advance precision radiation oncology
Int. J. Radiat. Oncol. Biol. Phys.
[19] Vogelius I R, Petersen J and Bentzen S M 2020 Harnessing data science to advance
radiation oncology Mol. Oncol.
[20] Siochi R A et al 2009 Information technology resource management in radiation oncology
J. Appl. Clin. Med. Phys.
[21] Bitterman D S, Miller T A, Mak R H and Savova G K 2021 Clinical natural language
processing for radiation oncology: a review and practical primer Int. J. Radiat. Oncol. Biol.
Phys.
110 641–55
[22] Higaki T, Nakamura Y, Tatsugami F, Nakaura T and Awai K 2019 Improvement of image
quality at CT and MRI using deep learning Jpn J. Radiol.
[23] Rusanov B et al 2022 Deep learning methods for enhancing cone-beam CT image quality
toward adaptive radiation therapy: a systematic review Med. Phys.
[24] Wong J et al 2020 Comparing deep learning-based auto-segmentation of organs at risk and
clinical target volumes to expert inter-observer variability in radiotherapy planning
Radiother. Oncol.
[25] Wang M, Zhang Q, Lam S, Cai J and Yang R 2020 A review on application of deep
learning algorithms in external beam radiotherapy automated treatment planning Front.
Oncol.
10 580919
[26] Huynh E et al 2020 Artificial intelligence in radiation oncology Nat. Rev. Clin. Oncol. 17
771–81
[27] Kessel K A and Combs S E 2015 Data management, documentation and analysis systems
in radiation oncology: a multi-institutional survey Radiat. Oncol.
[28] Abouelmehdi K, Beni-Hssane A, Khaloufi H and Saadi M 2017 Big data security and
privacy in healthcare: a review Procedia Comput. Sci.
[29] Pati S et al 2022 Federated learning enables big data for rare cancer boundary detection
Nat. Commun.
15 94–101
67
40 425–36
125
45 e793–810
95 871–2
101 285–91
14 1514–28
10 16–35
37 73–80
49 6019–54
144 152–8
10 230
113 73–80
13 7346
5-20

Artificial Intelligence in Adaptive Radiation Therapy
[30] Park S, Bekemeier B, Flaxman A and Schultz M 2022 Impact of data visualization on
decision-making and its implications for public health practice: a systematic literature
review Inform. Health Soc. Care.
[31] Van der Maaten L and Hinton G 2008 Visualizing data using t-SNE J. Mach. Learn. Res. 9
2579–605
[32] McNutt T R, Moore K L and Quon H 2016 Big data needs and challenges for big data in
radiation oncology Int. J. Radiat. Oncol. Biol. Phys.
[33] Pastorino R et al 2019 Benefits and challenges of big data in healthcare: an overview of the
European initiatives Eur. J. Public. Health
[34] Li T, Vedula S S, Hadar N, Parkin C, Lau J and Dickersin K 2015 Innovations in data
collection, management, and archiving for systematic reviews Ann. Intern. Med.
[35] Breiman L 2001 Random forests Mach. Learn. 45 5–32
[36] Guo G, Wang H, Bell D, Bi Y and Gree r K 2003 KNN model-based approach in
classification On The Move to Meaningful Internet Systems 2003: CoopIS, DOA, and
ODBASE. OTM 2003
pp 986–96
[37] Noble W S 2006 What is a support vector machine? Nat. Biotechnol. 24 1565–7
[38] Wickramasinghe I and Kalutarage H 2021 Naive Bayes: applications, variations and
vulnerabilities: a review of literature with code snippets for implementation Soft. Comput.
25 2277–93
[39] Ronneberger O, Fischer P and Brox T 2015 U-net: convolutional networks for biomedical
image segmentation Medical Image Computing and Computer-Assisted Intervention–
MICCAI 2015
[40] Milletari F, Navab N and Ahmadi S-A 2016 V-Net: fully convolutional neural networks for
volumetric medical image segmentation 2016 4th Int. Conf. on 3D Vision (3DV)
(Piscataway, NJ: IEEE) pp 565–71
[41] Long J, Shelhamer E and Darrell T 2015 Fully convolutional networks for semantic
segmentation Proc. of the IEEE Computer Society Conf. on Computer Vision and Pattern
Recognition vol 07–12(June 2015) (Piscataway, NJ: IEEE) pp 3431–40
[42] Dey R and Salemt F M 2017 Gate-variants of gated recurrent unit (GRU) neural networks
Midwest Symp. on Circuits and Systems (Piscataway, NJ: IEEE) pp 1597–600
[43] Staudemeyer R C and Morris E R 2019 Understanding LSTM—a tutorial into long short-
term memory recurrent neural networks arXiv:
[44] Vaswani A et al 2017 Attention is all you need Advances in Neural Information Processing
Systems vol 30 (Red Hook, NY: Curran Associates)
[45] Goodfellow I et al 2020 Generative adversarial networks Commun. ACM
[46] Gondara L 2016 Medical image denoising using convolutional denoising autoencoders
IEEE Int. Conf. on Data Mining Workshops, ICDMW
[47] Meng L, Ding S and Xue Y 2017 Research on denoising sparse autoencoder Int. J. Mach.
Learn. Cybern.
[48] Kingma D P and Welling M 2013 Auto-encoding variational Bayes arXiv: 1312.6114v11
[49] Chapelle O and Zien A 2005 Semi-supervised classification by low density separation Proc.
Mach. Learn. Res. R5 57–64
[50] Chong Y, Ding Y, Yan Q and Pan S 2020 Graph-based semi-supervised learning: a review
Neurocomputing
Lecture Notes in Computer Science vol 9351 (Berlin: Springer) pp 234–41
8 1719–29
Lecture Notes in Computer Science vol 2888 (Berlin: Springer)
408 216–30
47 175–93
95 909–15
29 23–7
162 287–94
1909.09586v1
63 139–44
pp 241–6
5-21

Artificial Intelligence in Adaptive Radiation Therapy
[51] Vien N A, Ertel W, Dang V H and Chung T 2013 Monte-Carlo tree search for Bayesian
reinforcement learning Appl. Intell.
[52] Jang B, Kim M, Harerimana G and Kim J W 2019 Q-learning algorithms: a comprehensive
classification and applications IEEE Access
[53] Bommasani R et al 2021 On the opportunities and risks of foundation models arXiv:
2108.07258v3
[54] Radford A and Narasimhan K 2018 Improving language understanding by generative pre-
training Open AI Blog
guage_understanding_paper.pdf
[55] Devlin J, Chang M W, Lee K and Toutanova K 2019 BERT: pre-training of deep
bidirectional transformers for language understanding Proc. Conf. of the North American
Chapter of the Association for Computational Linguistics: Human Language Technologies
vol 1 pp 4171–86
[56] Gu Y et al 2020 Domain-specific language model pretraining for biomedical natural
language processing ACM Trans. Comput. Healthc.
[57] Bolton E et al 2024 BioMedLM: a 2.7B parameter language model trained on biomedical
text arXiv:
[58] Huang K, Altosaar J and Ranganath R 2019 ClinicalBERT: modeling clinical notes and
predicting hospital readmission arXiv:
[59] Caron M et al 2021 Emerging properties in self-supervised vision transformers Proc. of the
IEEE Int. Conf. on Computer Vision (Piscataway, NJ: IEEE) pp 9630–40
[60] He K, Chen X, Xie S, Li Y, Dollar P and Girshick R 2022 Masked autoencoders are
scalable vision learners Proc. of the IEEE Computer Society Conf. on Computer Vision and
Pattern Recognition (2022-June) pp 15979–88
[61] Radford A et al 2021 Learning transferable visual models from natural language super-
vision Proc. Mach. Learn. Res 139 8748–63
[62] Liu H, Li C, Wu Q and Lee Y J 2023 Visual instruction tuning arXiv:
[63] Cai L, Gao J and Zhao D 2020 A review of the application of deep learning in medical
image classification and segmentation Ann. Transl. Med.
[64] Zhu W et al 2019 AnatomyNet: deep learning for fast and fully automated whole-volume
segmentation of head and neck anatomy Med. Phys.
[65] Isensee F, Jaeger P F, Kohl S A A, Petersen J and Maier-Hein K H 2021 nnU-Net: a self-
configuring method for deep learning-based biomedical image segmentation Nat. Methods
18 203–11
[66] Chen X et al 2021 A deep learning-based auto-segmentation system for organs-at-risk on
whole-body computed tomography images for radiation therapy Radiother. Oncol.
175–84
[67] Wong J et al 2021 Implementation of deep learning-based auto-segmentation for radio-
therapy planning structures: a workflow study at two cancer centers Radiat. Oncol.
[68] Urago Y et al 2021 Evaluation of auto-segmentation accuracy of cloud-based artificial
intelligence and atlas-based models Radiat. Oncol.
[69] Korte J C, Hardcastle N, Ng S P, Clark B, Kron T and Jackson P 2021 Cascaded deep
learning-based auto-segmentation for head and neck cancer patients: organs at risk on T2-
weighted magnetic resonance imaging Med. Phys.
[70] Lei Y et al 2021 Male pelvic multi-organ segmentation on transrectal ultrasound using
anchor-free mask CNN Med. Phys.
2403.18421v1
https://cdn.openai.com/research-covers/language-unsupervised/lan-
39 345–53
7 133653–67
3 24
1904.05342v3
2304.08485v2
8 713
46 576–89
160
16 101
16 175
48 7757–72
48 3055–64
5-22

Artificial Intelligence in Adaptive Radiation Therapy
[71] Podobnik G, Strojan P, Peterlin P, Ibragimov B and Vrtovec T 2023 HaN-seg: the head and
neck organ-at-risk CT and MR segmentation dataset Med. Phys.
[72] Valindria V V et al 2018 Multi-modal learning from unpaired images: application to multi-
organ segmentation in CT and MRI Proc. IEEE Winter Conf. on Applications of Computer
Vision(January) (Piscataway, NJ: IEEE) pp 547–56
[73] Cardenas C E et al 2021 Generating high-quality lymph node clinical target volumes for
head and neck cancer radiation therapy using a fully automated deep learning-based
approach Int. J. Radiat. Oncol. Biol. Phys.
[74] Qi X, Hu J, Zhang L, Bai S and Yi Z 2022 Automated segmentation of the clinical target
volume in the planning CT for breast cancer using deep neural networks IEEE Trans.
Cybern.
[75] Liu Z et al 2020 Development and validation of a deep learning algorithm for auto-
delineation of clinical target volume and organs at risk in cervical cancer radiotherapy
Radiother. Oncol.
[76] Fu J, Singhrao K, Qi X S, Yang Y, Ruan D and Lewis J H 2021 Three-dimensional
multipath DenseNet for improving automatic segmentation of glioblastoma on pre-
operative multimodal MR images Med. Phys.
[77] Hu S Y et al 2019 Multimodal volume-aware detection and segmentation for brain
metastases radiosurgery Artificial Intelligence in Radiation Therapy
Computer Science vol 11850 (Cham: Springer) pp 61–9
[78] Wang J Y et al 2023 Stratified assessment of an FDA-cleared deep learning algorithm for
automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery
Radiat. Oncol.
[79] Groendahl A R et al 2021 A comparison of methods for fully automatic segmentation of
tumors and involved nodes in PET/CT of head and neck cancers Phys. Med. Biol.
065012
[80] Xiang D, Zhang B, Lu Y and Deng S 2023 Modality-specific segmentation network for
lung tumor segmentation in PET-CT Images IEEE J. Biomed. Health Inform.
[81] Ma J, He Y, Li F, Han L, You C and Wang B 2024 Segment anything in medical images
Nat. Commun.
[82] Gibson E 2018 Multi-organ abdominal CT reference standard segmentations Data Set
Zendono
[83] Lambert Z, Petitjean C, Dubray B and Kuan S 2020 SegTHOR: segmentation of thoracic
organs at risk in CT images 2020 10th Int. Conf. on Image Processing Theory, Tools and
Applications, IPTA 2020
[84] Antonelli M et al 2022 The medical segmentation decathlon Nat. Commun.
[85] Kazerooni A F et al 2023 The Brain Tumor Segmentation (BraTS) Challenge 2023: focus on
pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs) arXiv:
[86] Bilic P et al 2023 The liver tumor segmentation benchmark (LiTS) Med. Image Anal. 84
102680
[87] Yan K, Wang X, Lu L and Summers R M 2018 DeepLesion: automatedmining of large-scale
lesion annotations and universal lesion detection with deep learning J. Med. Imag.
[88] Prior F et al 2017 The public cancer radiology imaging collections of the cancer imaging
archive Sci. Data
[89] Weinstein J N et al 2013 The Cancer Genome Atlas Pan-Cancer analysis project Nat.
Genet.
52 3446–56
153 172–9
18 61
15 654
4 170124
45 1113
109 801–12
48 2859–66
50 1917–27
Lecture Notes in
66
27 1237–48
13 4128
2305.17033v7
5 036501
5-23

Artificial Intelligence in Adaptive Radiation Therapy
[90] Gronberg M P, Gay S S, Netherton T J, Rhee D J, Court L E and Cardenas C E 2021
Technical note: Dose prediction for head and neck radiotherapy using a three-dimensional
dense dilated U-net architecture Med. Phys.
[91] Ahn S H et al 2021 Deep learning method for prediction of patient-specific dose distribution
in breast cancer Radiat. Oncol.
[92] Nguyen D et al 2019 A feasibility study for predicting optimal radiation therapy dose
distributions of prostate cancer patients from patient anatomy using deep learning Sci. Rep.
9 1076
[93] Bohara G, Sadeghnejad Barkousaraie A, Jiang S and Nguyen D 2020 Using deep learning
to predict beam-tunable pareto optimal dose distribution for intensity modulated radiation
therapy Med. Phys.
[94] Ma J et al 2021 A feasibility study on deep learning-based individualized 3D dose
distribution prediction Med. Phys.
[95] Wang W et al 2021 Deep learning-based fluence map prediction for pancreas stereotactic
body radiation therapy with simultaneous integrated boost Adv. Radiat. Oncol.
[96] Li X et al 2020 Automatic IMRT planning via static field fluence prediction (AIP-SFFP): a
deep learning algorithm for real-time prostate treatment planning Phys. Med. Biol.
175014
[97] Li Y et al 2023 Simultaneous dose distribution and fluence prediction for nasopharyngeal
carcinoma IMRT Radiat. Oncol.
[98] Shen C et al 2020 Operating a treatment planning system using a deep-reinforcement
learning-based virtual treatment planner for prostate cancer intensity-modulated radiation
therapy treatment planning Med. Phys.
[99] Zhang J, Späth S S, Marjani S L, Zhang W and Pan X 2018 Characterization of cancer
genomic heterogeneity by next-generation sequencing advances precision medicine in
cancer treatment Precis. Clin. Med.
[100] CuiY, Li B, PollomE L, Horst K C andLi R 2018 Integratingradiosensitivity and immunegene
signatures for predicting benefitofradiotherapyinbreastcancerClin. Cancer Res.
[101] Speers C et al 2020 A signature that may be predictive of early versus late recurrence after
radiation treatment for breast cancer that may inform the biology of early, aggressive
recurrences Int. J. Radiat. Oncol. Biol. Phys.
[102] Liveringhouse C L et al 2021 Genomically guided breast radiation therapy: a review of the
current data and future directions Adv. Radiat. Oncol.
[103] Abdollahi H et al 2022 Radiomics-guided radiation therapy: opportunities and challenges
Phys. Med. Biol.
[104] Cui S, Ten Haken R K and El Naqa I 2021 Integrating multiomics information in deep
learning architectures for joint actuarial outcome prediction in non-small cell lung cancer
patients after radiation therapy Int. J. Radiat. Oncol. Biol. Phys.
[105] Salome P et al 2022 Multi-omics classifier of tumor recurrence vs radiation-induced lung
fibrosis in NSCLC patients treated with SBRT Int. J. Radiat. Oncol. Biol. Phys.
[106] Wei L et al 2023 Artificial intelligence (AI) and machine learning (ML) in precision oncology:
a review on enhancing discoverability through multiomics integration Br.J.Radiol.
20230211
[107] Ford E C and Evans S B 2018 Incident learning in radiation oncology: a review Med. Phys.
45 e100–19
47 3898
67 12TR02
16 154
48 4438–47
18 110
1 29–48
48 5567–73
6 100672
65
47 2329–36
24 4754–62
108 686–96
6 100731
110 893–904
114 e388–9
96
5-24

Artificial Intelligence in Adaptive Radiation Therapy
[108] Luk S M H, Ford E C, Phillips M H and Kalet A M 2022 Improving the quality of care in
radiation oncology using artificial intelligence Clin. Oncol. (R. Coll. Radiol.)
[109] Han C et al 2023 Integrating plan complexity and dosiomics features with deep learning in
patient-specific quality assurance for volumetric modulated arc therapy Radiat. Oncol.
[110] Kalendralis P et al 2023 Automatic quality assurance of radiotherapy treatment plans using
Bayesian networks: a multi-institutional study Front. Oncol.
[111] Ford E C, Fong De Los Santos L, Pawlicki T, Sutlief S and Dunscombe P 2013 The
structure of incident learning systems for radiation oncology Int. J. Radiat. Oncol. Biol.
Phys.
86 11–2
[112] Nelson C, Roy L A and Wallace H J 2019 Radiation oncology incident learning system
(RO-ILS): increasing stakeholder participation for safety and quality improvement J. Clin.
Oncol.
37 232–2
[113] Luximon D C et al 2024 Results of an artificial intelligence-based image review system to
detect patient misalignment errors in a multi-institutional database of cone beam computed
tomography-guided radiation therapy Int. J. Radiat. Oncol. Biol. Phys.
[114] Moor M et al 2023 Foundation models for generalist medical artificial intelligence Nature
616 259–65
[115] Azad B et al 2023 Foundational models in medical imaging: a comprehensive survey and
future vision arXiv:
[116] Li Q et al 2024 Progress and opportunities of foundation models in bioinformatics Brief.
Bioinform.
[117] Moon S, Pakhomov S, Liu N, Ryan J O and Melton G B 2014 A sense inventory for
clinical abbreviations and acronyms created using clinical notes and medical dictionary
resources J. Am. Med. Inform. Assoc.
[118] Johnson A E W et al 2016 MIMIC-III, a freely accessible critical care database Sci. Data 3
160035
[119] Pollard T J, Johnson A E W, Raffa J D, Celi L A, Mark R G and Badawi O 2018 The eICU
Collaborative Research Database, a freely available multi-center database for critical care
research Sci. Data
[120] Pandy A, Harangi B and Hajdu A 2023 Extracting drug names from medical reports Int.
Scientific and Technical Conf. on Computer Sciences and Information Technologies
(Piscataway, NJ: IEEE)
[121] Ayers J W et al 2023 Comparing physician and artificial intelligence chatbot responses to
patient questions posted to a public social media forum JAMA Intern. Med.
[122] Van Veen D et al 2024 Adapted large language models can outperform medical experts in
clinical text summarization Nat. Med.
[123] Agaronnik N D, Lindvall C, El-Jawahri A, He W and Iezzoni L I 2020 Challenges of
developing a natural language processing method with electronic health records to identify
persons with chronic mobility disability Arch. Phys. Med. Rehabil.
[124] Li T et al 2024 CancerGPT for few shot drug pair synergy prediction using large pretrained
language models npj Digit. Med.
[125] Yousefzadeh M et al 2021 AI-corona: radiologist-assistant deep learning framework for
COVID-19 diagnosis in chest CT scans PLoS One
[126] Kim C et al 2024 Transparent medical image AI via an image–text foundation model
grounded in medical literature Nat. Med.
25 bbae548
2310.18689v1
21 299–307
5 180178
30 1134–42
7 40
16 e0250952
30 1154–65
13 1099994
101 1739–46
34 89–98
18 116
120 243–52
183 589–96
5-25

Artificial Intelligence in Adaptive Radiation Therapy
[127] Betker J et al 2023 Improving image generation with better captions Open AI Blog https://
cdn.openai.com/papers/dall-e-3.pdf
[128] Adams L C, Busch F, Truhn D, Makowski M R, Aerts H J W L and Bressem K K 2023
What does DALL-E 2 know about radiology? J. Med. Internet Res.
[129] Barrett T et al 2013 NCBI GEO: archive for functional genomics data sets—update Nucleic
Acids Res.
[130] Berman H M et al 2000 The protein data bank Nucleic Acids Res. 28 235–42
[131] Song B, Li Z, Lin X, Wang J, Wang T and Fu X 2021 Pretraining model for biological
sequence data Brief. Funct. Genom.
[132] Cui H et al 2024 scGPT: toward building a foundation model for single-cell multi-omics
using generative AI Nat. Methods
[133] Chen J et al 2022 Interpretable RNA foundation model from unannotated data for highly
accurate RNA structure and function predictions arXiv:
[134] Benegas G, Albors C, Aw A J, Ye C and Song Y S 2023 GPN-MSA: an alignment-based
DNA language model for genome-wide variant effect prediction BioRxiv
[135] Benary M et al 2023 Leveraging large language models for decision support in personalized
oncology JAMA Netw. Open
[136] Zhuang F et al 2021 A comprehensive survey on transfer learning Proc. IEEE 109 43–76
[137] Saraswat D et al 2022 Explainable AI for healthcare 5.0: opportunities and challenges IEEE
Access
[138] Seoni S, Jahmunah V, Salvi M, Barua P D, Molinari F and Acharya U R 2023 Application
of uncertainty quantification to artificial intelligence in healthcare: a review of last decade
(2013–2023) Comput. Biol. Med.
41 D991–5
20 181–95
2024 1470–80
2204.00300v5
6 e2343689–e29
10 84486–517
165 107441
25 e43110
202 561776
5-26
Соседние файлы в папке Библиотека им академика М.И. Перельмана
